hims glp-1 results & Hers swings to a loss in Q1 amid shift in strategy Hims & Hers shares rally
Description
doi: 10.1002/cne.901940306
GLP 1 therapy helps control these risk factors at the root level
Managing type 2 diabetes in people with advanced chronic kidney disease (CKD) and end-stage kidney disease (ESKD) on dialysis presents unique clinical challenges
The other half began taking a DPP-4 inhibitor comparator "gliptins," a different class of diabetes medications, the study noted
[DOI] [PubMed] [Google Scholar] 710.McCrimmon R.J., Shaw M., Fan X., Cheng H., Ding Y., Vella M.C
Z Gastroenterol 1994
